Alnylam Pharmaceuticals, Inc. (ALNY) Reports Q3 Loss of 31c/Share
Go back to Alnylam Pharmaceuticals, Inc. (ALNY) Reports Q3 Loss of 31c/Share| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 294.06 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $294.06 | 52 Week High | $109.10 | |||
| Open | $294.06 | 52 Week Low | $31.38 | |||
| Day High | $294.06 | P/E | N/A | |||
| Day Low | $294.06 | EPS | $-1.45 | |||
| Volume | 109 | |||||
